Keywords: good, results, tysabri, rms, trial, irish, biotechnology

Good results for Tysabri RMS trial

Article | 29 September 2008

Print This

Irish biotechnology company Elan and USA-based Biogen Idec presented data on a post-hoc analysis of the Phase III AFFIRM trial, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in